after taking the hrts began having a regular menstrual cycle after going 15 months without a period putting me in menapause. Menapausal symptoms managable, but why bleeding? Is this normal - will it subside?
- Resources
Q: have been using evamist for 2 months and on my second dose of prometrium for 10 days of the month -
Answers (1)
7/ 9/09 3:47pm
Yes, this sounds normal. Taking the hormone therapy as you are taking it, 10 days/month, may keep you bleeding. If you had gone 15 months without a period, your body is probably pretty close to quitting. You might stop the cycling by taking the Prometrium everyday. This is perfectly safe. If you continue to breakthrough and bleed or have spotting, it's a good indication that your body is not ready to stop. I also like the continuous dosing because progesterone is very helpful with sleep and mood issues, so the more you are on it through the month, the more help you'll get with those symptoms.
Good luck,
Sandy
Important:
We hope you find this general health information helpful. Please note however, that this Q&A is meant to support not replace the professional medical advice you receive from your doctor. No information in the Answers above is intended to diagnose or treat any condition. The views expressed in the Answers above belong to the individuals who posted them and do not necessarily reflect the views of The HealthCentral Network. The HealthCentral Network does not review or edit content posted by our community members, but reserves the right to remove any material it deems inappropriate.
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
